Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research Read More » June 27, 2024
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera Read More » June 25, 2024
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma Read More » June 19, 2024
Bio-Rad Launches ddSEQ™ Single-Cell 3′ RNA-Seq Kit for Single-Cell Gene Expression Read More » June 19, 2024
Alveo’s Portable, Rapid Molecular Diagnostic Platform Proves Unshakable in Rigorous Ruggedness Tests Read More » June 18, 2024